Cellectar Biosciences Inc (CLRB)

[oddone33320]

Cellectar Biosciences Announces Participation in Two Upcoming Investor Conferences in September

Webcasts Available Through Cellectar Corporate Website

MADISON, Wis., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection and treatment of cancer, announced that Dr. Simon Pedder, chief executive officer, will be presenting a company overview at the Rodman & Renshaw 16th Annual Global Investment Conference being held September 8 - 10, 2014 at the New York Palace Hotel in New York and the Aegis Capital Healthcare and Technology Conference being held September 10 - 13, 2014 at the Encore at Wynn in Las Vegas.

Event: Rodman & Renshaw 16th Annual Global Investment Conference
Date: Tuesday, September 9, 2014
Time: 1:40 p.m. Eastern Time
Location: New York Palace Hotel, New York, NY


Event: Aegis Capital Healthcare and Technology Conference
Date: Thursday, September 11, 2014
Time: 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time)
Location: Encore at Wynn, Las Vegas, NV
Live audio webcasts of both the Rodman & Renshaw presentation and the Aegis Capital presentation will be available on the Company's website on the Investor Relations Events page at http://investor.cellectar.com/events.cfm. The webcast replays will be available approximately two hours after each presentation ends and will be accessible for 90 days.